Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Global Blood Ther (GBT)

Global Blood Ther (GBT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,630,559
  • Shares Outstanding, K 60,231
  • Annual Sales, $ 0 K
  • Annual Income, $ -174,190 K
  • 60-Month Beta 1.71
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 7.01

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -1.19
  • Number of Estimates 10
  • High Estimate -1.13
  • Low Estimate -1.30
  • Prior Year -0.93
  • Growth Rate Est. (year over year) -27.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
48.21 +59.47%
on 11/14/19
79.95 -3.84%
on 12/09/19
+26.64 (+53.03%)
since 11/13/19
3-Month
44.17 +74.05%
on 10/08/19
79.95 -3.84%
on 12/09/19
+22.84 (+42.26%)
since 09/13/19
52-Week
34.92 +120.16%
on 12/24/18
79.95 -3.84%
on 12/09/19
+34.27 (+80.43%)
since 12/13/18

Most Recent Stories

More News
Why Is Global Blood (GBT) Up 68.2% Since Last Earnings Report?

Global Blood (GBT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

GBT : 76.88 (-0.01%)
% Return Seen to Date on SmarTrend Global Blood The Call (GBT)

SmarTrend identified a Downtrend for Global Blood The (NASDAQ:GBT) on November 19th, 2019 at $53.61. In approximately 2 weeks, Global Blood The has returned 48.01% as of today's recent price of $79.35....

GBT : 76.88 (-0.01%)
Global Blood The Set to Possibly Pullback After Yesterday's Rally of 4.86%

Global Blood The (NASDAQ:GBT) traded in a range yesterday that spanned from a low of $70.95 to a high of $73.31. Yesterday, the shares gained 4.9%, which took the trading range above the 3-day high of...

GBT : 76.88 (-0.01%)
GBT Announces New Employment Inducement Grants

Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on December 1, 2019, the compensation committee of GBT's board of directors granted 21 new employees options to purchase an aggregate...

GBT : 76.88 (-0.01%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (PBYI , GBT , DVAX , INCY , EXAS )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

DVAX : 6.92 (+5.97%)
GBT : 76.88 (-0.01%)
PBYI : 9.36 (+0.75%)
Biotech Tops in November: Best ETFs & Stocks

The biotech space of the broad healthcare sector outperformed others in November, courtesy of a series of positive news including study results, regulatory backdrop and deal activities.

CNCR : 23.06 (-0.39%)
BBC : 36.20 (-0.60%)
BBP : 43.61 (+0.17%)
GBT : 76.88 (-0.01%)
PTI : 4.25 (+3.66%)
VRTX : 218.98 (-0.71%)
CLVS : 12.86 (-4.24%)
MYOV : 15.05 (-4.32%)
CNST : 39.38 (+0.77%)
KRTX : 65.25 (-11.24%)
CRSP : 65.36 (-1.01%)
ARKG : 34.54 (+0.09%)
GNOM : 16.20 (+1.62%)
The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG

The Zacks Analyst Blog Highlights: GLD, CRSP, GBT, ALNY and ARKG

GLD : 139.05 (+0.45%)
ALNY : 117.74 (-2.38%)
GBT : 76.88 (-0.01%)
CRSP : 65.36 (-1.01%)
ARKG : 34.54 (+0.09%)
The Zacks Analyst Blog Highlights: Intercept, CymaBay, Amgen, Global Blood Therapeutics and ChemoCentryx

The Zacks Analyst Blog Highlights: Intercept, CymaBay, Amgen, Global Blood Therapeutics and ChemoCentryx

GBT : 76.88 (-0.01%)
ICPT : 114.16 (-1.53%)
AMGN : 236.74 (+0.32%)
CCXI : 31.41 (-5.62%)
CBAY : 2.06 (+19.77%)
Global Blood (GBT) in Focus: Stock Moves 5.2% Higher

Global Blood (GBT) shares rose more than 5% in the last trading session, amid huge volumes.

GBT : 76.88 (-0.01%)
ALKS : 20.87 (-1.79%)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CLVS , INSM , GBT , ARWR, SRPT )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

CLVS : 12.86 (-4.24%)
GBT : 76.88 (-0.01%)
INSM : 23.21 (+0.30%)
ARWR : 66.46 (-1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade GBT with:

Business Summary

Global Blood Therapeutics, Inc. is a biopharmaceutical company which is engaged in discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. Its product candidate consists of GBT440 is an oral, once-daily prophylactic therapy for sickle cell disease which...

See More

Key Turning Points

2nd Resistance Point 78.99
1st Resistance Point 77.94
Last Price 76.88
1st Support Level 75.56
2nd Support Level 74.23

See More

52-Week High 79.95
Last Price 76.88
Fibonacci 61.8% 62.75
Fibonacci 50% 57.43
Fibonacci 38.2% 52.12
52-Week Low 34.92

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar